News|Articles|May 30, 2013

REDUCE MRSA Trial Lead Author Discusses Landmark Paper in CDC's Healthcare Blog

Today, on CDC's Safe Healthcare blog, lead author of the REDUCE MRSA trial, Dr. Susan Huang, discusses the results of the landmark study and provides insight into what the findings mean for infection prevention and patient safety.

The REDUCE MRSA trial found that using germ-killing soap and ointment on all intensive-care unit (ICU) patients could reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs.

Huang is an associate professor at the University of California Irvine School of Medicine and medical director of epidemiology and infection prevention at UC Irvine Health.

Join the conversation by clicking HERE.


Related to this article

Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.